Silicosis in Australia: How Engineered Stone Created a New Generation of Lung Disease

By Dr. Alberto Augsten, Toxicologist and Psychopharmacologist

Australia became the global epicenter of a rapid and devastating resurgence of silicosis among workers fabricating engineered stone benchtops. Once thought to be a disease of nineteenth-century miners, accelerated silicosis began appearing in young Australian stonemasons in the mid-2010s, prompting some of the strictest national workplace silica regulations in the world — and an unprecedented 2024 nationwide ban on the import, supply, and use of engineered stone.

The Toxicology of Crystalline Silica

Respirable crystalline silica (RCS) is fine particulate quartz, cristobalite, or tridymite small enough to penetrate the deep lung. Once deposited in the alveoli, silica particles are engulfed by macrophages and trigger oxidative stress, inflammasome activation (NLRP3), apoptosis, and chronic inflammation. Over years, this produces classic silicosis: progressive pulmonary fibrosis with characteristic radiographic nodular opacities. RCS exposure is also linked to lung cancer (IARC Group 1), COPD, chronic kidney disease, and autoimmune disorders including systemic sclerosis.

Why Engineered Stone Was Different

Engineered stone benchtops contain up to 95 percent crystalline silica — dramatically higher than natural granite (around 30 percent). Dry cutting, grinding, and polishing of these slabs generates intense bursts of respirable silica dust. Workers in poorly ventilated fabrication shops, often using dry cutting techniques and inadequate respiratory protection, accumulated lifetime silica doses in a few years that previously took decades of mining work to produce.

The Australian Outbreak

Queensland was the first Australian state to report clustered cases of accelerated silicosis among engineered-stone workers starting around 2015. National Dust Disease Taskforce surveillance subsequently identified hundreds of cases across Australia, many in workers under 40, with rapid progression to pulmonary fibrosis, transplant requirement, and death. Some workers developed silicosis after only a few years of exposure.

The 2024 National Ban

In July 2024, Australia became the first country in the world to ban the manufacture, supply, processing, and installation of engineered stone benchtops, slabs, and panels. The ban followed Safe Work Australia recommendations and was supported by unions, public-health advocates, and many employer groups. It is being closely watched globally as other nations (UK, US, Canada, EU member states) consider similar restrictions.

Clinical Features and Management

Accelerated and chronic silicosis present with progressive dyspnea, cough, and on imaging show small nodular opacities concentrated in the upper lobes, progressing in some patients to large fibrotic masses (progressive massive fibrosis). High-resolution CT is sensitive. There is no disease-modifying treatment; care focuses on smoking cessation, pulmonary rehabilitation, treatment of complications (mycobacterial infection is more common in silicotic lungs), and lung transplant assessment in advanced disease.

Clinical and Public-Health Takeaways

For clinicians anywhere in the world, the Australian experience reframes silicosis as a contemporary, fast-moving occupational disease, not a historical curiosity. Stonemasons, dental laboratory workers, construction trades involved in concrete cutting, sandblasters, and miners all warrant baseline respiratory assessment and exposure histories. The Australian ban illustrates that decisive primary prevention is possible — but only after a substantial cohort of young workers had already been irreversibly harmed.